Member Login

Forgot your password?

Logged-In Members: Renew


ImageGuide Registry

The nation's first registry for
non-invasive cardiac imaging.

See the benefits and how to enroll!




ImageGuide Registry: Nuclear Cardiology's MACRA Reporting Solution

Nuclear cardiology practices from across the United States are enrolling in ASNC's ImageGuide Registry, a decision that positions them to fulfill Medicare's new reporting requirements and advance their quality-improvement goals, all while making few administrative changes and, for ASNC members, incurring no new costs.  

ASNC, IAC and SNMMI Call for Field to Focus on Radiation Dose Optimization in Nuclear Cardiology

Working in concert, the American Society of Nuclear Cardiology (ASNC), the IntersocietalAccreditation Commission (IAC)'s Nuclear/PET accreditation division and the Society of Nuclear Medicine inMolecular Imaging (SNMMI) are mandating optimized radiation doses in conjunction with the nuclear cardiology studies (i.e., myocardial perfusion imaging) performed throughout the United States and beyond. 

Announcing ASNC's 2016 Choosing Wisely Challenge Winners

ASNC's Nuclear Cardiology Choosing Wisely Challenge made its stage debut in Boca Raton, Fla., when the three competition finalists presented their proposals for ensuring that patients get the right test at the right time. The winner was selected by a panel of judges and ASNC2016 attendees, who voted via audience-response system. 

Health Canada Approves Cardiac AdreView; Launch of ADMIRE-ICD Clinical Trial

Health Canada has approved a cardiac indication for AdreView (Iobenguane I 123 Injection). In Canada, AdreView is indicated for scintigraphic assessment of sympathetic innervation of the myocardium in patients with NYHA II-III HF and LVEF ≤35 percent. 

ASNC's New Position Statement Identifies 5 Situations Where PET is Recommended

Two new documents published jointly by ASNC and the Society of Nuclear Medicine and Molecular Imaging assess the value and quality of myocardial perfusion PET imaging. 

ASNC Announces New PET Position Statement and New PET Clinical Guidelines

More than 25 experts from around the world and two leading professional organizations assess the value and quality of myocardial perfusion PET imaging.

Join ASNC's ImageGuide Registry Info Session on Aug. 29

ASNC Registry Oversight Committee Chair Peter Tilkemeier, MD, MMM, FASNC, will present need-to-know information about the changing U.S. healthcare environment and answer your questions about how ImageGuide Registry participation can help you succeed. 

ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures

An updated joint American Society of Nuclear Cardiology (ASNC) imaging guidelines and SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures has just been published addressing the areas of PET myocardial perfusion and metabolism clinical imaging. The new guideline provides imaging guidelines for physicians and technologists who are qualified to practice nuclear cardiology.

ASNC's ImageGuide Registry Earns QCDR Designation for 2016

The Centers for Medicare & Medicaid Services has recognized ASNC's ImageGuide Registry as a Qualified Clinical Data Registry (QCDR) for 2016. The designation allows ImageGuide Registry–participating physicians the opportunity to meet Physician Quality Reporting System (PQRS) requirements by reporting on quality measures. Negative payment adjustments under PQRS are expected to increase with the implementation of the Medicare Access and CHIP Reauthorization Act's MIPS program.

New! ASNC Publishes Comprehensive Information Statement on Imaging and Cancer

Approximately 14.5 million people with a current or prior cancer diagnosis are living in the United States today, and the National Cancer Institute expects this population to grow to 19 million in the next decade. A new information statement published by ASNC helps cardiologists, cardiac imaging specialists, cardio-oncologists and oncologists understand the implications of a cancer history on patients' current and future cardiovascular care. In this comprehensive statement, clinicians will find—